Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Physitrack

11.20 SEK+5.16 %15.10, 16.02
Less than 1K followers

PTRK

First North Stockholm

Software

Technology

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+5.16 %
+28.15 %
+47.37 %
+23.89 %
-14.50 %
-34.50 %
-38.12 %
-81.33 %
-75.91 %

Physitrack operates in the healthcare sector and specializes in physiotherapy. The product portfolio includes digital healthcare offerings for companies via SaaS solutions. In addition to the main business, personal service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe and North America. Physitrack was founded in 2012 and is headquartered in London.

Read more
Market cap
182.12M SEK
Turnover
428.09K SEK
Revenue
146.05M
EBIT %
-45.34 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
Tämän nyt ei enää pitäisi tulla yllätyksenä, eli EMR julkaistu. Physitrack Launches Next-Generation EMR, Powered by Agentic AI Physitrack plc (Nasdaq First North: PTRK) launches AI agentic EMR that turns the consultation itself into the clinical record, moving the company from a ...
9/28/2026, 8:18 AM
by kettunen
3
Opening up the US market, quite a decent-sized contract compared to Physitrack’s previous ones and a testament to the system’s capability. MFN – 7 Sep 26 Physitrack PLC: Physitrack Wins Deal with Large US Healthcare Syste... Three-year enterprise agreement with a total contract value...
9/7/2026, 9:35 AM
by kettunen
2
Q2 out storage.mfn.se q2-2026-interim-report-english.pdf Reasonable growth percentages, though moderate in absolute terms. Cash flow positive in Q2, which is a good situation for a cost-heavy quarter. The RTM product in the US market has started generating revenue; this likely holds...
7/21/2026, 6:37 AM
by kettunen
2
True, it’s stable. Fortunately, we are slowly drifting forward anyway. I’d prefer to see slightly stronger figures before the US listings. By the way, we’ve drifted quite close to Redeye’s bear case again: Physitrack - Redeye Are there any other analysts still covering this?
5/4/2026, 1:23 PM
by Von Wangell
2
Let’s keep going, the number of sign-ups for the trial is growing pretty well 1,000 clinics in 9 days – there’s definitely demand and interest More on the EMR from there. On the surface, it really looks like quite a capable helper Physitrack Physical Therapy EMR / PMS | Physitrack...
10/7/2026, 12:28 PM
by kettunen
1
A pretty good start for the trial period https://x.com/physitrack/status/2106401806850883876 Let’s add today’s press release about the commercial model and preliminary pricing here as well Physitrack sets out commercial model for its EMR as more than 100 clinics sign up for early...
10/3/2026, 7:27 PM
by kettunen
1
Another US deal in a row. Starting to look considerably better Physitrack Selected by US Metropolitan Healthcare System for Enterprise-Wide, Epic-Integrated Digital Rehabilitation Three-year enterprise agreement with a total three year contract value of approximately US$78,000 (approximate...
9/14/2026, 6:27 AM
by kettunen
1
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20.10
2026

Interim report Q3'26

26.2
2027

Annual report '26

Press release13.10.2026, 08.30

Invitation to Physitrack PLC Q3 2026 interim report webcast conference

Physitrack
Regulatory press release12.10.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release09.10.2026, 15.30

Physitrack EMR Waitlist Reaches 2,100 Practitioners as Commercial Rollout Accelerates

Physitrack

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release05.10.2026, 10.00

Physitrack sets out commercial model for its EMR as more than 100 clinics sign up for early access in five days

Physitrack
Regulatory press release05.10.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release02.10.2026, 13.21

Redeye: Physitrack (Q3 Preview): Steady Growth, EMR in Focus

Physitrack
Press release28.09.2026, 12.57

Redeye: Physitrack: EMR launch marks shift from add-on to system of record

Physitrack
Regulatory press release28.09.2026, 11.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release28.09.2026, 08.30

Physitrack Launches Next-Generation EMR, Powered by Agentic AI

Physitrack
Regulatory press release21.09.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release14.09.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release14.09.2026, 07.45

Physitrack Selected by US Metropolitan Healthcare System for Enterprise-Wide, Epic-Integrated Digital Rehabilitation

Physitrack
Press release07.09.2026, 11.01

Physitrack Wins Deal with Large US Healthcare System Following Competitive Process

Physitrack
Regulatory press release07.09.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release31.08.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release26.08.2026, 08.00

Physitrack PLC: Notification of Managers' Transactions

Physitrack
Regulatory press release24.08.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release17.08.2026, 08.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release10.08.2026, 10.45

Physitrack commences share buyback program

Physitrack
Regulatory press release06.08.2026, 12.20

Physitrack PLC — Notification of Managers' Transactions

Physitrack